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ORIGINAL ARTICLEAcidoCEST-UTE MRI for the Assessment of Extracellular
pH of Joint Tissues at 3 TYa-Jun Ma, PhD,*† Rachel A. High, PhD,*† Qingbo Tang, PhD,*† Lidi Wan, MD,*†
Saeed Jerban, PhD,*† Jiang Du, PhD,*† and Eric Y. Chang, MD*†Objectives: The goal of this study was to demonstrate feasibility of measuring
extracellular pH in cartilage and meniscus using acidoCEST technique with a
3-dimensional ultrashort echo time readout (acidoCEST-UTE) magnetic reso-
nance imaging (MRI).
Materials and Methods: Magnetization transfer ratio asymmetry, radiofre-
quency (RF) power mismatch, and relative saturation transfer were evaluated in
liquid phantoms for iopromide, iopamidol, and iohexol over a pH range of 6.2
to 7.8, at various agent concentrations, temperatures, and buffer concentrations.
Tissue phantoms containing cartilage andmeniscus were evaluated with the same
considerations for iopamidol and iohexol. Phantoms were imaged with the
acidoCEST-UTE MRI sequence at 3 T. Correlation coefficients and coefficients
of variations were calculated. Paired Wilcoxon rank-sum tests were used to eval-
uate for statistically significant differences.
Results: The RF power mismatch and relative saturation transfer analyses of liq-
uid phantoms showed iopamidol and iohexol to be the most promising agents for
this study. Both these agents appeared to be concentration independent and feasi-
ble for use with or without buffer and at physiologic temperature over a pH range
of 6.2 to 7.8. Ultimately, RF power mismatch fitting of iohexol showed the strongest
correlation coefficients between cartilage,meniscus, and fluid. In addition, ratiometric
values for iohexol are similar among liquid as well as different tissue types.
Conclusions: Measuring extracellular pH in cartilage and meniscus using
acidoCEST-UTE MRI is feasible.
Key Words:MRI, chemical exchange saturation transfer, pH, osteoarthritis,
acidoCEST
(Invest Radiol 2019;54: 565–571)
O steoarthritis is a common disease that has substantial impact on af-fected individuals, healthcare systems, and society as a whole.1
Imaging is important for the diagnosis and management of osteoar-
thritis, and magnetic resonance imaging (MRI) is widely considered
the most comprehensive modality for assessment of the joint.2 Con-
ventional clinical MRI is highly sensitive for gross morphological
abnormities, such as chondral fissures or meniscal tears. Using more
research-oriented, relaxation-based techniques, including T2, T2*,
dGEMRIC, and T1ρ, more sensitive quantitative measurements can
be made on joint tissues.3 Of note, however, all of these methodsReceived for publication January 31, 2019; and accepted for publication, after revi-
sion, April 3, 2019.
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fortunately, the reality is that once the collagen network is degraded,
it has reached an irreversible state.4 Furthermore, structural assess-
ment can be limited due to its poor correlations with patient symp-
toms.5 Development of imaging techniques that identify earlier
changes or provide complementary information that may improve
correlations with patient symptoms would be highly beneficial.
It is nowwidely accepted that osteoarthritis is not just a structural
wear-and-tear disease, but an active, biochemically mediated process.6
An important component of normal physiology and tissue function is
acid-base homeostasis and pH regulation. For instance, degradation of
the extracellular matrix of cartilage is orchestrated bymatrix metallopro-
teinases and a disintegrin and metalloproteinase with thrombospondin
type I motifs.7 Expression and function of several of these proteins
are influenced by extracellular pH (pHe).8,9 In addition, aberrant
neurovascular invasion at the osteochondral junction is mediated by os-
teoclasts, which dissolve mineral by massive acid secretion.10,11 The
nociceptors in these osteochondral channels and in osteoarthritic me-
nisci can be either directly activated or sensitized by protons through
acid-sensing ion channels.12,13
Recently, pHe-sensitive MRI has been performed with chemical
exchange saturation transfer (CEST) after administration of Food and
Drug Administration– and European Medicines Agency–approved
contrast agents typically used with computed tomography (CT), termed
acidoCEST MRI.14 AcidoCEST measures the CEST signals produced
by the exchange of protons between amide side chains and water. The
CEST signal is linearly correlated with pH because the exchange is
base-catalyzed.15 Evaluation of tissue pH using acidoCEST has primar-
ily focused on oncologic applications16,17 and has not yet been used on
diarthrodial joint tissues. Furthermore, readouts used with acidoCEST
have included gradient sequences (spoiled or steady-state), fast-spin
echo (FSE), or echo planar imaging, all with typically longer echo
times. These techniques would be less optimal for musculoskeletal tis-
sues with short transverse relaxation times, such as deep layers of carti-
lage when oriented parallel to B0
18,19 and menisci, for which ultrashort
echo time (UTE) sequences would be more ideal.20
The purpose of our study was to show feasibility of measuring
pHe in cartilage and menisci using the acidoCEST technique with a
3-dimensional (3D) UTE readout (acidoCEST-UTE) on a 3 T clinical
scanner. Toward this goal, numerous experimental variables were investi-
gated, including (1) those related to the solution (contrast agent, concentra-
tion, presence of buffer, and temperature), (2) those related to the sequence
(saturation power), and (3) those related to signal processing (ratiometric
analysis based on saturation transfer [ST] or radiofrequency [RF] power).MATERIALS AND METHODS
This phantom and ex vivo study was exempted from institutional
review board approval.
Chemicals
Commercially purchased stock solutions of iopamidol at 972 mM
concentration (370mg I/mL Isovue; Bracco Imaging S.p.A,Milan, Italy),
iopromide at 972 mM concentration (370 mgI/mL Ultravist; Bayer
Healthcare Pharmaceuticals LLC, Berlin, Germany), and iohexol atwww.investigativeradiology.com 565
ealth, Inc. All rights reserved.
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Chicago, IL) were used in this study. All other chemicals were purchased
from Sigma-Aldrich (St Louis, MO).
Phantom Preparation
An initial set of samples was prepared with all 3 contrast agents
at 50 and 200 mM concentrations using either concentrated phosphate-
buffered saline (PBS) to achieve a final concentration of 10mM of PBS
or normal saline without buffer. For each condition, pH of samples was
varied between 6.2 and 7.8 as measured with a calibrated pH electrode
(LE422, FiveEasy F20 bench meter; Mettler Toledo, Columbus, OH).
To further assess the effects of buffer, phantoms were created using
iopamidol or iohexol and phosphate-buffered saline to achieve
200 mM final contrast concentration and 5, 10, 20, and 40 mM final
concentrations of phosphate-buffered saline for pH 6.6 and 7.2. A sec-
ond set of phantoms was created using iopamidol and iohexol and con-
centrated phosphate-buffered saline to achieve 30 to 300 mM contrast
concentration and 10mM final concentration of phosphate-buffered sa-
line at pH values of 6.6 and 7.2. A third set of ex vivo cartilage and me-
nisci tissue phantoms were created using iopamidol and iohexol
between 100 to 400 mM concentration and 10 mM final concentration
of phosphate-buffered saline at pH values ranging between 6.2 and 7.8.
Only grossly normal tissues were used in this study, harvested from 4
male donors (31, 53, 54, and 80 years of age at death). In brief, coins
of pure cartilage were created from osteochondral cores, all from vari-
ous locations within the joint. Menisci slices were also harvested. Tis-
sues were soaked in the solution for at least 96 hours, and solutions
and tissue surface pH values were tested using an electrode (LE427
solid tissue electrode, FiveEasy F20 bench meter; Mettler Toledo,
Columbus, OH) after scanning to ensure pH stability. All phantoms
were cylindrical in shape, either in sealed plastic transfer pipette heads
or syringes. These phantoms were then placed into a cylindrical con-
tainer filled with Fomblin (Ausimont, Thorofare, NJ) and scanned par-
allel to B0 at isocenter to minimize susceptibility. All 3 sets of phantoms
were scanned at both 23°C and at physiologic temperature (35°C),
which was maintained using an MRI-compatible, regulated air heater
that was created in-house with a hair-dryer fan, insulated hoses, fiberFIGURE 1. The acidoCEST-UTE sequence. A Fermi pulse was used to create CE
the scan (A). Each excitation uses a short rectangular pulse (duration = 16 μs)
time-efficient sampling with a minimal TE of 32 μs (C). Data acquisition windo
repetition time; TE, echo time; RF, radiofrequency; Gx,y,z, gradient in x,y,z dire
566 www.investigativeradiology.com
Copyright © 2019 Wolters Kluwer Hoptic sensors, and a Styrofoam box. Temperatures inside of the box
were tested and could be maintained within ±0.2°C for over 4 hours.
Magnetic Resonance Imaging
All imaging was performed on a 3 T clinical scanner (MR750,
GE Healthcare, Milwaukee, WI) using an 8-channel transmit/receive
knee coil. The 3D UTE sequence using spiral trajectories with conical
view ordering was used for the readout.21,22 For the liquid phantom
scans, the 3D acidoCEST-UTE sequence (Fig. 1) parameters used were
as follows: TR = 62 milliseconds, TE = 0.032 milliseconds, number of
spokes (Nsp) = 5, spoke interval (τ) = 5 milliseconds, flip angle
(FA) = 5 degrees, BW = 166 kHz, field of view = 12 12 11.2 cm3,
and matrix = 160  160  28. Chemical exchange saturation transfer
contrast was created with a Fermi pulse: duration = 32 milliseconds,
bandwidth = 40 Hz, B1s = 0.54 (300 degrees) and 1.1 μT (600 degrees)
as calculated by power average,23 55 frequency offsets from −1080 to
1080 Hz in 40 Hz increments, with 1 minute and 10 seconds of scan time
per frequency. Steady-state before acquisition was achieved using an
8-second dummy scan. For the ex vivo cartilage and meniscus phantom
scans, the sequence parameters were identical to the liquid phantoms
except for higher resolution (field of view = 12 12 14.4 cm3, ma-
trix = 160  160  48) and resultant 2-minute scan time per fre-
quency. Three-dimensional FSE images were also obtained using
higher in-plane resolution at 256  256, TR = 1600 milliseconds,
and TE = 40 milliseconds to improve visibility of tissue structures
and boundaries. To correct for B0 inhomogeneity, a dual-echo UTE se-
quence with TEs = 0.032 and 2.2 milliseconds were used to generate
the B0 map with other sequence parameters including FA = 8 degrees,
TR = 20 milliseconds, and half in-plane resolution and same through-
plane resolution as the CEST sequence.
Data Analysis
All data were processed using a home-developed MATLAB
code (The Mathworks, Inc, Natick, MA, R2016b). Each frequency-
offset datum was smoothed using a 3D Gaussian kernel with standard
deviation of 0.8. The Z-spectrum was then obtained by interpolating
the frequency-offset data points with splines to determine the exactST contrast followed by the multiple spokes (Nsp) excitation to accelerate
for signal excitation (B), followed by a 3D Cones trajectory to allow
w (DAW) starts at the beginning of the readout gradient. TR indicates
ctions; FID, free induction decay.
© 2019 Wolters Kluwer Health, Inc. All rights reserved.
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4.2, 4.3, and 5.6 ppm). All data were then corrected by frequency
shifting based on the measured B0 maps. The magnetization transfer
ratio asymmetry (MTRasym) was calculated by:
MTRasym Δwð Þ ¼ I −Δwð Þ−I Δwð ÞI0  100; ½1
whereΔw is the frequency offset. I(Δw) and I(−Δw) are the signal inten-
sities at the frequency offsets of Δw and −Δw, respectively. I0 is the sig-
nal intensity without the saturation pulse. Moreover, the ST was
determined by
ST Δwð Þ ¼ I −Δwð Þ−I Δwð Þ
I −Δwð Þ  100: ½2
Based on the obtained MTRasym and ST values, the ratio of the RF
power mismatch (RPM)24 and the relative saturation transfer (RST)25
can be determined by
RPM Δwð Þ ¼ 100−MTRasym Δwð Þ
 
=MTRasym Δwð Þ
 
RF1
100−MTRasym Δwð Þ
 
=MTRasym Δwð Þ
 
RF2
½3
and
RST Δwð Þ ¼ 100−ST Δwð Þð Þ=ST Δwð Þ½ peak1
100−ST Δwð Þð Þ=ST Δwð Þ½ peak2
; ½4FIGURE 2. Comparison between iopromide, iopamidol, and iohexol at 35°C.
RPM values at both 4.2 and 5.6 ppm (C), and RST values at both 0.54 and 1.1
Z-spectrum at pH = 6.3 (F), RPM values at both 4.2 and 5.6 ppm (G), and RS
chemical structure (I), Z-spectrum at pH = 6.3 (J), and RPM values at 4.3 ppm
saturation transfer; ppm, parts per million.
© 2019 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2019 Wolters Kluwer Hrespectively. The index RF 1 and RF 2 refer to 2 different RF powers at
the same CEST peak. Peak 1 and peak 2 refer to 2 different CEST peaks
at the same power. For the RPM calculations for all the CEST peaks in
iopromide (4.2 and 5.6 ppm), iopamidol (4.2 and 5.6 ppm), and iohexol
(4.3 ppm), the FA of RF 1 is lower than that of RF 2. For the RST cal-
culations of iopromide and iopamidol, the frequency offsets of peak 1
and peak 2 are 5.6 ppm and 4.2 ppm, respectively.
Statistical Analysis
Statistical calculations were performed using SPSS (SPSS ver-
sion 21; SPSS, Chicago, IL). The paired Wilcoxon rank-sum test was
used to evaluate for statistically significant differences between
MTRasym for each of the contrast agents with or without added buffer
and at when scanned at 23°C and 35°C. P values less than 0.05 were
considered statistically significant. The coefficient of variation for the
iopamidol and iohexol with 0 to 40 mM buffer was calculated as
CoV = standard deviation/mean.
RESULTS
Iopamidol and iopromide both carry unique amide groups,
which produce CEST effects at 4.2 and 5.6 ppm (Fig. 2, A and E),
whereas iohexol contains one amide group that produces CEST effect
at 4.3 ppm (Fig. 2I). A comparison between the 3 agents at 200 mM
contrast concentration, pH 6.3, and at 35°C highlights Z-spectra differ-
ences, with notable increases in MTRasym as FA increases from 0.54 to
1.1 μT (Fig. 2, B, F, and J). From pH6.2 to 7.8 at 35°C,MTRasym ranges
for iopromide at 0.54 μTwere 3.32 to 9.24 at 4.2 ppm and 0.68 to 2.0 atThe first row shows the chemical structure (A), Z-spectrum at pH = 6.3 (B),
μT (D) for iopromide. The second row shows the chemical structure (E),
T values at 0.54 and 1.1 μT (H) for iopamidol. The third row shows the
(K) for iohexol. RPM indicates ratio of RF power mismatch; RST, relative
www.investigativeradiology.com 567
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FIGURE 3. Investigation of CEST effects versus contrast agent concentrations for both liquid and tissue phantoms at 35°C. The first row shows the RPM
values at 4.2 ppm for iopamidol (A), RST values at 1.1 μT for iopamidol (B), and RPM values at 4.3 ppm for iohexol (C) of the liquid phantomwith 2 pH
values of 6.6 and 7.2. The concentrations of both iopamidol and iohexol liquid phantom range from 30 to 300 mM. The second row shows the RPM
values at 4.2 ppm for iopamidol (D), RST values at 1.1 μT for iopamidol (E), and RPM values at 4.3 ppm for iohexol (F) of the tissue phantom including
both cartilage andmeniscus at pH 6.6. The concentrations of both the iopamidol and iohexol tissue phantoms range from 100 to 300mM. RPM indicates
ratio of RF power mismatch; RST, relative saturation transfer; ppm, parts per million; mM, millimolar.
Ma et al Investigative Radiology • Volume 54, Number 9, September 20195.6 ppm, and at 1.1 μTwere 11.84 to 15.93 at 4.2 ppm and 2.96 to 8.83 at
5.6 ppm. For iopamidol at 35°C,MTRasym ranges at 0.54 μTwere 3.14 to
15.49 at 4.2 ppm and 1.52 to 5.14 at 5.6 ppm, and at 1.1 μTwere 12.62 to
30.62 at 4.2 ppm and 6.59 to 15.41 at 5.6 ppm. For iohexol at 35°C,
MTRasym ranges at 4.3 ppm were 4.05 to 13.08 at 0.54 μT and 14.66 to
25.77 at 1.1 μT. For iopromide, RPM for these 2 FAs yielded better
performance for the 4.2 ppm peak compared with the 5.6 ppm peak
(Fig. 2C). For iopamidol, the RPM for the 4.2 ppm peak performed
better than the 5.6 ppm peak (Fig. 2G). For iohexol, the 4.3 ppm peak
showed good performance (Fig. 2K). Of the 3 agents, RPM for the
4.2 ppm peak using iopamidol showed the most linear relationship
with pH. RST did not perform well for iopromide (Fig. 2D) or
iopamidol (Fig. 2H). Based on these data, iopamidol and iohexol were
selected for use in the subsequent phantom studies, so as to include 1 agent
with 2 CEST peaks and 1 with 1 CEST peak. Iopamidol was selected over
iopromide due to having a larger maximal CESTeffect over the tested pH
range (30.62 vs 15.93, respectively, for the 4.2 ppm peak at 1.1 μT irradi-
ation). Subsequent tests with iopamidol focused on RPM at the 4.2 ppm
peak, as this showed amore linear relationship to pH than the 5.6 ppmpeak
or with RST analysis.
Varying contrast agent concentration from 50 to 300 mM in liq-
uid phantoms had no notable effect on RPM at 4.2 ppm for pH 6.6 or
7.2 using iopamidol (Fig. 3A) or iohexol (Fig. 3C). Relative saturation
transfer of iopamidol at pH 6.6 and 7.2 were likewise not notably af-
fected over the same range of concentrations (Fig. 3B). Similar results
were obtained using phantoms containing cartilage and meniscus sam-
ples in a pH 6.6 solution at a range of concentration from 100 to
300 mM (Fig. 3, D–F).
With regards to the effect of buffer at 23°C, a paired Wilcoxon
rank-sum test showed that there was no significant difference in568 www.investigativeradiology.com
Copyright © 2019 Wolters Kluwer HMTRasym for 200 mM of iopamidol with or without added 10 mM buffer
for pH 6.2 to 7.8 at the 4.2 ppm peak using B1 values of 0.54 μT
(P = 0.345) and 1.1 μT (P = 0.255), or at the 5.6 ppm peak at 0.54 μT
(P = 0.225) and 1.1 μT (P = 0.893). Similarly, a Wilcoxon rank-sum test
showed that there was no significant difference in MTRasym for 200 mM
of iohexol with or without added buffer for pH 6.2 to 7.8 at 0.54 μT
(P = 0.138) and 1.1 μT (P = 0.080) at 23°C. Assessment of 200 mM
of iopamidol with 0 to 40 mM phosphate-buffered saline at 35°C
demonstrated a 3.9% to 13.2% CoV for RPM at 5.6 ppm (Supplemen-
tary Fig. 1A, Supplemental Digital Content 1, http://links.lww.com/
RLI/A437) and 6.8% to 12.8% at 4.2 ppm (Supplementary Fig. 1B,
Supplemental Digital Content 1, http://links.lww.com/RLI/A437).
Assessment of 200 mM of iohexol with 0 to 40 mM phosphate-buffered
saline at 35°C demonstrated a 5.9% to 7.5% CoV for RPM at 4.3 ppm
(Supplementary Fig. 1C, Supplemental Digital Content 1, http://links.
lww.com/RLI/A437).
For iopamidol, a paired Wilcoxon rank-sum test showed that
overall CEST effects increased from room temperature to physiologic
temperature (35°C) for the 4.2 ppm peak at 1.1 μT (P = 0.005), although
no significant difference was detected at 0.54 μT (P = 0.386). For the
5.6 ppm peak of iopamidol, a paired Wilcoxon rank-sum test showed
that CEST effects decreased at both 0.54 μT (P = 0.017) and 1.1 μT
(0.047). A pairedWilcoxon rank-sum test showed that overall CESTef-
fects for iohexol decreased at 1.1 μT (P = 0.005), although no signifi-
cant difference was detected at 0.54 μT (P = 0.241).
Phosphate-buffered phantoms containing 200 mM of contrast
and samples of cartilage and meniscus were evaluated over a pH range
of 6.2 to 7.8, and fit of each curve from tissuewas compared with the fit
of the fluid portion of the respective phantom. RF power mismatch of
iopamidol was evaluated at 4.2 ppm (Fig. 4A), as well as RST at 1.1 μT© 2019 Wolters Kluwer Health, Inc. All rights reserved.
ealth, Inc. All rights reserved.
FIGURE 4. Comparison of CEST effects of fluid, cartilage, and meniscus in the tissue phantom with 200 mM of contrast at 35°C. RPM values at 4.2 ppm
for iopamidol (A), RST values at 1.1 μT for iopamidol (B), and RPM values at 4.3 ppm for iohexol (C) for fluid, cartilage, andmeniscus are presentedwith
circles, squares, and triangles, respectively. The corresponding linear regression curves are shown with the measured R2 values in the bottom row. RPM
indicates ratio of RF power mismatch; RST, relative saturation transfer.
Investigative Radiology • Volume 54, Number 9, September 2019 AcidoCEST-UTE for pH Imaging of Joint Tissues(Fig. 4B). RF power mismatch of iohexol was evaluated at 4.3 ppm
(Fig. 4C) and shows superior correlations between fluid, cartilage, and me-
niscus. Notably, the slope and intercepts between fluid and tissues are the
most similar for iohexol. Figure 5A shows the composition of the tissue
phantoms, and Figure 5B shows a representative FSE image that was used
to delineate the boundaries of cartilage and meniscus to facilitate ROI
selection for analysis. Pixel maps of pH were generated for the iohexol
phantoms using the fluid fit as a calibration curve, with the equation
y = 1.56 −8.39 (Fig. 5C). The pH of fluid within each phantomwas con-
firmed with a pH meter before and after scanning. Based on the MTRasym
values in the cartilage and menisci after 96 hours of soaking in 200 mM
solution, contrast concentrations reached ~100 mM in the tissue.DISCUSSION
In this study, we investigated the capability of the acidoCEST-
UTE technique to measure pHe in liquid phantoms and ex vivo carti-
lage and menisci phantoms using a 3 T clinical scanner. Assessment
of joint tissue pHe may have considerable significance, but has only
been previously performed using highly invasive electrodes during
open joint surgery.9 The results from our study suggest that bathingFIGURE 5. Phantoms containing both cartilage andmeniscus immersed in 200
are calculated basedon the RPM fittingmethod for iohexol at 35°C. The constru
on a 3D fast spin echo image (B). Pixel-wise pHmaps of both cartilage and me
6.2 to 7.8. The pH calibration was derived from the fluid inside of the phanto
© 2019 Wolters Kluwer Health, Inc. All rights reserved.
Copyright © 2019 Wolters Kluwer Hthe joint tissues with Food and Drug Administration– and European
Medicines Agency–approved iodinated contrast agents (specifically
iohexol or iopamidol), allowing sufficient time for contrast diffusion
into the tissues, and subsequent scanning with the acidoCEST-UTE
technique may be an alternative method to electrode testing for measure-
ment of pHe. Of note, intra-articular injection of contrast is minimally in-
vasive and routinely performed in clinical practice (eg, conventional
radiographic, CT, or MR arthrography). For routine clinical CT
arthrography of the knee, typically 35 to 50 mL of total volume is
injected26 and 50% to 100% of the total volume can consist of iodinated
contrast.27 Compared with other exogenous CEST MRI applications,
where contrast is injected intravenously and must permeate the tissue of
interest, the diarthrodial joint may be unique in that direct administration
of contrast is relatively easy and commonly performed. Much higher lo-
cal contrast concentrations and therefore higher CEST effects would be
expected compared with intravenous administration of contrast.
Clinically compatible pHe-sensitive imaging techniques have re-
ceived increasing interest in recent years, and a number of techniques
have been explored, including optical imaging techniques,28 positron
emission tomography,29 and multinuclear MR spectroscopy.30 However,
each of these techniques has practical limitations for in vivo translation,mM iohexol with varying pH, confirmed using an electrode. The pHmaps
ction of the tissue phantom is demonstratedwith a photograph (A) and
niscus (C) are shown with the corresponding fluid pH values ranging from
m.
www.investigativeradiology.com 569
ealth, Inc. All rights reserved.
Ma et al Investigative Radiology • Volume 54, Number 9, September 2019including depth limitations, requirements for radioactive compounds
produced by cyclotrons, and limited spatial resolution, respectively.
Other pHe-sensitive MRI techniques also exist, including gagCEST31
and R1ρ dispersion32; however, these may be less suitable for pH mea-
surement of joint tissues because they are both sensitive to changes in
tissue composition, such as glycosaminoglycans.33,34 The acidoCEST
technique overcomes most of these limitations. Specifically, the whole
joint can be imagedwith sufficient spatial resolution to identify individ-
ual joint structures; iohexol and iopamidol are available off-the-shelf,
and both are already approved for intra-articular administration. Fur-
thermore, pHe imaging with acidoCEST is not confounded by varia-
tions in local glycosaminoglycan concentration.31
A number of iodinated contrast agents have been used with the
acidoCEST technique. However, to our knowledge, only iopamidol
has been investigated on a 3 T clinical scanner.17,35 Using the
acidoCEST-UTE technique at 3 T, we compared iopromide, iohexol,
and iopamidol, and found that all 3 agents were sensitive to pH using
one of the ratiometric approaches. Overall, our results are consistent
with previous studies that have also found significant correlations be-
tween CEST ratios and pH with iopromide,14,31,36 iopamidol,25,36–38
and iohexol.39 However, iopromide demonstrated the lowest CESTef-
fects of the three. Similar to our results, Moon et al36 performed a
comparison between iopromide and iopamidol, and found lower
CESTeffect for both the 4.2 and 5.6 ppm peaks with iopromide com-
pared with iopamidol.
Saturation powers ranging from 0.54 (300 degrees) to 1.1 μT
(600 degrees) were used in our study, which is in range with previous
3 T acidoCEST studies that used saturation powers from 0.2 μT to 1.5
μT.17,35 Although the saturation efficiency with the powers used in
our study was sufficient to detect CESTeffects in phantoms and in vivo,
the larger CESTeffect was seen with 1.1 μT irradiation over 0.54 μT, as
expected. When using a knee coil for RF transmission, even higher
powers than 1.1 μT can be used while still operating with specific ab-
sorption rate limitations.34 When using higher powers, however, other
considerations such as increasing contributions from magnetization
transfer40 or broadening resulting in inadvertent saturation of other fre-
quencies should be kept in mind.
We also examined several other variables that affect pH quantifi-
cation, including contrast concentration, buffer type, and temperature.
For the range of contrast concentrations used in this experiment (30 to
300 mM), both iohexol and iopamidol with ratiometric analyses were
concentration independent. Our results are similar to a number of previ-
ous studies, including Müller-Lutz et al35 who found that iopamidol
was concentration-independent when imaged at 3 T over a range of
20 to 160 mM. Buffers should be considered for CESTexperiments be-
cause they can potentially alter exchange rates in a complex manner.41
Themechanism is not fully understood, but the effect can differ between
exchange sites present on the same molecule.42 Our results suggest that
the presence and concentration of phosphate buffer does not signifi-
cantly alter CEST effects or ratiometric analyses at the amide group
peaks on iohexol or iopamidol. With regards to temperature, higher
temperatures increase water exchange rates, resulting in broader CEST
peaks.43 The effect on CESTeffect depends in part on the exchange rate
at a particular field strength and can also differ between exchange sites
present on the same molecule.43,44 Overall, our results indicate that
CEST effects increased from room temperature to 35°C for iohexol
and iopamidol at the 4.2 ppm peak, but mildly decreased for the
5.6 ppm peak on iopamidol. Our iopamidol results are similar to those
reported by Moon et al.36 Ratiometric analyses differed between the 2
temperatures; however, confirming that calibration with pH should be
made at the appropriate temperature.
In addition to the conventional ST ratiometric approach, we used
the RF power-based ratiometric approach as described by Longo et al.24
For iopamidol, we found comparable performance of the ST ratio com-
pared with the RF power-based ratio at 4.2 ppm. However, iohexol570 www.investigativeradiology.com
Copyright © 2019 Wolters Kluwer Hcontains only a single set of amide protons, and therefore can only be an-
alyzed using the RF power-based ratiometric approach. Overall, our re-
sults suggest that iohexol is the preferred agent because the strongest
correlation coefficients between ratiometric analyses and pH were seen.
Furthermore, an important consideration that supports the use of iohexol
is the very similar ratiometric (RPM) values between liquid, cartilage, and
meniscus. Use of a single pH calibration scale that is composition inde-
pendent would facilitate interpretation. Longo et al37 found that RSTaf-
ter iopamidol administration yielded similar values between liquid and
tumor homogenate. The differences in our results may be related to dif-
ferences in scanner performance (preclinical vs clinical) or in tissue
composition (homogenized tumor vs solid musculoskeletal tissue).
Our study has several limitations. First, our ex vivo tissues were
soaked for 96 hours to ensure homogeneous contrast diffusion and pH
equilibration based on prior literature.45 Notable differences in vivo exist,
including considerably shorter times for contrast penetration. Specifi-
cally, contrast flux is greatly accelerated with mechanical convection,
and adequate contrast penetration could be expected in as short as 1 hour
in a patient who is mobile,46 particularly with nonionic contrast agents
such as those used in our study.47 Furthermore, local pH would be ex-
pected to be maintained in the in vivo condition. Chen et al14 previously
demonstrated that the pH of the injection solution did not influence the
tumor tissue pH measurement when performed in vivo. In the joint, pH
of tissue extracellular matrix is maintained by resident cells such as
chondrocytes, and is typically lower than that of synovial fluid.6 Second,
the scan time for the acidoCEST-UTE technique is long, in part due to the
use of multiple RF irradiation powers. However, for future in vivo studies,
it would be recommended that the total number of datasets be lowered,
focused near the frequencies of the CEST effect (±4.3 ppm in the case
of iohexol). In addition, other opportunities for acceleration exist, includ-
ing smaller coverage in the patient's location of pain, increasing the num-
ber of Cones spokes per preparation,22 and utilization of parallel imaging
or compressed sensing reconstruction. Third, an alternative method of
data analysis involves fitting of the CEST spectra using Bloch equations
modified for chemical exchange. Although this has been reported to be
superior to ratiometric analyses,17 unfortunately many more datasets are
required over ratiometric approaches. Therefore, this is less suited for
in vivo imaging of the knee using 3D sequences. Fourth, CEST tech-
niques are expected to perform better at higher field strengths, and future
experiments should consider use of 7 T scanners, which are nowavailable
for human use.48,49 Finally, our techniquewas used on ex vivo tissue only,
and we have not yet translated the acidoCEST-UTE technique in humans.
However, due to the large number of considerations examined in this
study, identification of the best contrast agent and technique variables be-
fore human use ismandatory. In an upcoming experiment, we plan to per-
form the technique in subjects who will undergo subsequent total knee
replacement, thus providing the opportunity to correlate MR and elec-
trode pH measurements as well as potentially demonstrate the signifi-
cance of the pH measurement.
In conclusion, measuring pHe in cartilage and meniscus using
acidoCEST-UTE MRI is feasible.REFERENCES
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